DIFFERENTIAL-EFFECTS OF POLYSULFATED POLYSACCHARIDE ON EXPERIMENTAL ENCEPHALOMYELITIS, PROLIFERATION OF AUTOIMMUNE T-CELLS, AND INHIBITION OF HEPARANASE ACTIVITY

被引:29
作者
HERSHKOVIZ, R
MOR, F
MIAO, HQ
VLODAVSKY, I
LIDER, O
机构
[1] WEIZMANN INST SCI,DEPT CELL BIOL,IL-76100 REHOVOT,ISRAEL
[2] HEBREW UNIV JERUSALEM,HADASSAH HOSP,DEPT ONCOL,IL-91120 JERUSALEM,ISRAEL
关键词
D O I
10.1006/jaut.1995.0055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The extravasation of activated T lymphocytes through blood vessel walls and their migration to inflammatory loci are associated with secretion of extracellular matrix (ECM)-degrading enzymes, such as heparanase, which degrades heparan sulfate (HS) moieties of the ECM. The HS-degrading activity of heparanase was found to be inhibited by HS and heparin. Since induction of experimental autoimmune encephalomyelitis (EAE) requires extravasation and migration of autoimmune T cells, degradation of ECM by heparanase is expected to be involved in induction of the disease, Herein, we examined whether laminarin sulfate, a polysulfated polysaccharide (PSS) isolated from the cell walls of seaweeds and subjected to chemical sulfation, could inhibit ECM degradation by mammalian heparanase, and could prevent EAE, PSS was a more potent inhibitor of heparanase-mediated degradation of ECM than heparin. In-vivo, PSS, injected once a week, inhibited the severity of actively-induced EAE in rats. However, inhibition of EAE was not due to an overall suppression of autoimmune T cells, since PSS enhanced the proliferation of myelin basic protein (MBP)-specific, encephalitogenic T cells. PSS-activated autoimmune T cells, but not MBP-activated cells, failed to induce EAE in recipient rats. Moreover, rats injected with PSS-activated T cells were resistant to induction of EAE by anti-MBP CD4(+) T cells. Thus, PSS may have potential clinical applications in the treatment of autoimmune diseases. (C) 1995 Academic Press Limited
引用
收藏
页码:741 / 750
页数:10
相关论文
共 30 条
[1]  
ALON R, 1994, J IMMUNOL, V152, P1304
[2]  
ARFORS KE, 1993, J LAB CLIN MED, V121, P201
[3]  
BARNER M, 1987, BLOOD, V70, P551
[4]  
BENNUN A, 1982, J IMMUNOL, V128, P1450
[5]  
FRIDMAN R, 1986, J CELL PHYSL, V130, P85
[6]  
GILAT D, 1994, J IMMUNOL, V153, P4899
[7]  
HAN ZY, 1991, CHINESE MED J-PEKING, V104, P562
[8]  
HERSHKOVIZ R, 1994, J IMMUNOL, V153, P554
[9]  
HIGASHIYAMA S, 1991, J CELL BIOL, V122, P933
[10]   INTEGRINS - VERSATILITY, MODULATION, AND SIGNALING IN CELL-ADHESION [J].
HYNES, RO .
CELL, 1992, 69 (01) :11-25